Bacterial vaginosis

Shift in vaginal flora

© Judy Arbique

Apr 14, 2007
Clue cells in vaginal discharge, CDC/M. Rein
Bacterial vaginosis is a condition in which the normal flora of the vagina has been disrupted shifting from the predominance of Lactobacillus species to an overgrowth of

The pH is the vagina is normally acidic (pH <4.5). Normal vaginal bacteria (predominantly Lactobacillus) thrive in this acidic environment; whereas, other more harmful bacteria prefer a more alkaline environment. Conditions that disrupt the normal acid pH of the vagina may predispose to infection with harmful bacteria or other microorganisms that overgrow in the less acidic environment shifting the bacterial population, or that gain entry through sexual activity (sexually transmitted diseases).

The causes of bacterial vaginosis are relatively poorly understood; however, the following activities have been associated with a greater risk of infection:

  • having a new sex partner,
  • having multiple sex partners
  • douching
  • using an intrauterine contraception device (IUD)

Bacterial vaginosis is suggested by the presence of “Clue cells” seen during microscopic examination of vaginal fluids. Symptoms associated with bacterial vaginosis commonly include a thin white or grey discharge and an unpleasant odor (fish-like odor, especially after intercourse). Additional symptoms may include pain, itching and burning. Vaginosis may also be asymptomatic, where the woman is not experiencing symptoms, but microscopic examination shows the absence of Lactobacillus (long, Gram-positive rods) and the presence of “clue cells”.

“Clue cells” are vaginal epithelial cells that are so coated with bacteria that their edges are difficult to discern. The bacterial population associated with vaginosis include Gram-negative and Gram-variable rods and cocci (e.g. G. vaginalis, Prevotella, Porphyromonas, and peptostreptococci), and curved Gram-negative rods (Mobiluncus). Inflammatory cells are not usually seen in microscopic preparations of vaginal fluids from women with bacterial vaginosis – one of the reasons why the condition is referred to as vaginosis rather than vaginitis. The term vaginitis suggests an infection associated with the presence of inflammatory cells (neutrophils), commonly seen in vulvovaginal candidiasis or Trichomonas vaginalis infections.

Bacterial vaginosis is diagnosed by clinical symptoms and laboratory microscopic examination of vaginal fluids (Gram stain). Three of the following clinical criteria are required to diagnose bacterial vaginosis:

  • thin, white discharge that smoothly coats vaginal walls,
  • presence of clue cells on microsopic examination,
  • pH >4.5 of vaginal fluid,
  • fish-like odor of vaginal discharge (the addition of 10% KOH results in a release of fishy odor, and is commonly referred to as the "whiff" test.

Bacterial vaginosis may resolve without treatment; however, the Centres for Disease Control and Prevention (CDC) recommend that all women with symptoms be treated to avoid complications that include a greater predisposition to sexually transmitted diseases and/or pelvic inflammatory disease. Evidence does not suggest that bacterial vaginosis is sexually transmitted; therefore male partners are not generally treated. Bacterial vaginosis may spread between female sexual partners, however.

Symptomatic pregnant women should be treated, as well as asymptomatic pregnant women with history of premature delivery or low birth weight babies. The CDC estimated that as many as 16% of pregnant women in the U.S. have bacterial vaginosis.

Bacterial vaginosis during pregnancy has been associated with:

  • premature rupture of the membranes,
  • preterm labor,
  • preterm birth,
  • intraamniotic infection, and
  • postpartum endometritis.

The recommended treatments for bacterial vaginosis include the antibiotics metronidazole or clindamycin, both of which are safe for use during pregnancy. A 7-day treatment protocol is generally used: shorter treatment regimens may be associated with recurrence of bacterial vaginosis. It is extremely important to complete the full treatment protocol prescribed by your physician, even after symptoms resolve.

Related Content:

Vaginitis: Vulvovaginal Candidiasis

Trichomonas vaginalis

Source:

Bacterial vaginosis (CDC Fact Sheet)


The copyright of the article Bacterial vaginosis in Microbiology is owned by Judy Arbique. Permission to republish Bacterial vaginosis in print or online must be granted by the author in writing.




Post this Article to facebook Add this Article to del.icio.us! Digg this Article furl this Article Add this Article to Reddit Add this Article to Technorati Add this Article to Newsvine Add this Article to Windows Live Add this Article to Yahoo Add this Article to StumbleUpon Add this Article to BlinkLists Add this Article to Spurl Add this Article to Google Add this Article to Ask Add this Article to Squidoo

Comments
Dec 5, 2007 1:29 PM
ingedorthe :
Judy Arbique's article contains lots of good facts. But are few are to be challenged:
The antibiotic treatment by metronidazole has immidiate effect, but for many women the BV returns after a few weeks. Again and again.
A certain complication of treatment with antibiotic is fungal infection.
Metronidazole is a suspected carcinogen, banned in Europe for treating animals for that reason - but recommended for women - strange....
In Europe the continous treatment with lactose tablets (LadyBalance) are getting common - this natural remedy strenghtens the womans own lactic acid bacteria, and eliminates most general vaginal nuisances, especially the fishy smell. More information on www.ladybalance.com
Dec 16, 2007 9:05 AM
Judy Arbique :
The Centers for Disease Control and Prevention stills recommends metronidazole or clindamycin for treatment of bacterial vaginosis. At least one study, however, has reported resurgence of the bacteria associated with vaginosis after metronidazole treatment cessation (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView& amp;TermToSearch=18005928&ordinalpos=4&itool=EntrezSystem2.PEntrez. Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum).

I was unable to find any published reports on the effectiveness of lactose tablets for treating bacterial vaginosis in the scientific literature. Is your information anecdotal only or are there published reports of clinical trials showing the effectiveness of this treatment.
Feb 10, 2008 12:23 PM
ingedorthe :
You are right that no double-blinded controlled clinical trials are yet published on lactose tablets.
The evidence is based on the following:
The logic based on microbiological physiology, that when lactic acid bacteria are supplied with their favorite nutrient, they grow and produce acid. Gardnerella, Candida and others does not metabolize lactose and are suppressed by the acid.
The feedback from uncontrolled trial persons, where all (ten) women using the LadyBalance to combat discharge with bad smell reported a significant improvement. See http://www.ladybalance.com/side.asp?mid=8&id=31
The positive feedback from a large number of users in Europe.

A professional wants to see clinical proof. But I can tell, that making practitioners participate in a trial like this is nearly impossible. We are in the process of reformulating the trial to advertise to get trial persons, as none were supplemented from the practitioners participating in the trial.
3 Comments